G

Guangdong Marubi Biotechnology Co Ltd
SSE:603983

Watchlist Manager
Guangdong Marubi Biotechnology Co Ltd
SSE:603983
Watchlist
Price: 33.56 CNY -2.27%
Market Cap: 13.5B CNY
Have any thoughts about
Guangdong Marubi Biotechnology Co Ltd?
Write Note

Gross Margin
Guangdong Marubi Biotechnology Co Ltd

72.7%
Current
68%
Average
31.7%
Industry

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
72.7%
=
Gross Profit
1.9B
/
Revenue
2.6B

Gross Margin Across Competitors

Country CN
Market Cap 13.8B CNY
Gross Margin
73%
Country FR
Market Cap 181.7B EUR
Gross Margin
74%
Country UK
Market Cap 114.1B GBP
Gross Margin
0%
Country IN
Market Cap 5.5T INR
Gross Margin
52%
Country UK
Market Cap 34.9B GBP
Gross Margin
62%
Country DE
Market Cap 27.8B EUR
Gross Margin
58%
Country US
Market Cap 27B USD
Gross Margin
72%
Country JP
Market Cap 3T JPY
Gross Margin
38%
Country IN
Market Cap 1.1T INR
Gross Margin
56%
Country IN
Market Cap 903.7B INR
Gross Margin
49%
Country US
Market Cap 9.9B USD
Gross Margin
35%
No Stocks Found

Guangdong Marubi Biotechnology Co Ltd
Glance View

Market Cap
13.5B CNY
Industry
Consumer products

Guangdong Marubi Biotechnology Co Ltd stands as a compelling narrative of innovation and heritage in the realm of beauty and skincare. Established in 2002, the company has carved a niche in China’s competitive cosmetics industry by blending advanced biotechnology with traditional skincare practices. This fusion forms the backbone of Marubi’s product portfolio, which spans an array of skincare solutions including anti-aging serums, hydrating masks, and rejuvenating creams. The company’s strength lies in its robust research and development framework, where scientific rigor meets the potential of natural ingredients, leading to the formulation of effective skincare products. By fostering partnerships with renowned research institutions, Marubi ensures that its offerings are not only well-aligned with consumer expectations but also backed by solid scientific evidence. In the financial landscape, Marubi’s operational model is keenly focused on understanding consumer trends and leveraging digital marketing strategies to solidify its market position. A significant portion of the company’s revenues is generated through e-commerce platforms, which tap into China’s rapidly growing online retail market. Emphasizing brand loyalty and customer engagement, Marubi has utilized social media and collaborations with influencers to promote its products and extend its reach beyond traditional retail channels. Moreover, the company has established a keen presence in offline sales, ensuring its brand stands out in both bustling urban centers and emerging local markets. Through this strategic synergy between online and offline sales avenues, Guangdong Marubi Biotechnology Co Ltd thrives as a modern skincare powerhouse, creating value continuously in an ever-evolving market landscape.

Intrinsic Value
31.9 CNY
Overvaluation 5%
Intrinsic Value
Price
G

See Also

Discover More
What is Gross Margin?

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
72.7%
=
Gross Profit
1.9B
/
Revenue
2.6B
What is the Gross Margin of Guangdong Marubi Biotechnology Co Ltd?

Based on Guangdong Marubi Biotechnology Co Ltd's most recent financial statements, the company has Gross Margin of 72.7%.